CARAMEL is a European Union-funded initiative under the Horizon Europe Programme, addressing an often-overlooked health concern: cardiovascular disease in women aged 40 to 60. Research highlights that women in this age range, particularly those going through perimenopause and menopause, face a significantly heightened risk of cardiovascular issues. Despite this, the risk is frequently underestimated by both medical professionals and the women affected. CARAMEL seeks to close this gap by combining co-designed methodologies with clinical data, medical imaging, wearable technology, and personal health information. The project is dedicated to refining cardiovascular risk assessment models, ensuring they are specifically tailored to the unique needs of women in this life stage. Through this effort, women gain the knowledge and tools necessary to better understand their heart health and implement personalized prevention strategies, securing the medical attention and care they need.

Within CARAMEL, Timelex serves as the legal and ethical advisor and a member of the Gender and Ethics Committee. It ensures GDPR, AI, health, and data-sharing compliance. Key tasks include drafting privacy policies, informed consent, DPIAs, joint controllership agreements, and reviewing clinical protocols. Timelex will deliver key legal and ethical reports at M36 and M54.

More information about the CARAMEL project can be found on the project website: Home - CARAMEL Project and the project page on the CORDIS website: Cardiovascular Risk Assessment in Menopausal women via multimodal data analysis enabling personalized prevention strategies | CARAMEL | Project | Fact sheet | HORIZON | CORDIS | European Commission.